These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3815349)

  • 41. Hepatic acetylator phenotype in diabetes mellitus.
    Ladero JM; Arrojo A; de Salamanca RE; Gomez M; Cano F; Alfonso M
    Ann Clin Res; 1982 Aug; 14(4):187-9. PubMed ID: 7168549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Undernourished adults and acetylation phenotype.
    Arunkumar Shastri R
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):194-6. PubMed ID: 7076349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of sulfamethazine acetylation by hydrocortisone in the rabbit.
    Reeves PT; Minchin RF; Ilett KF
    Drug Metab Dispos; 1988; 16(1):110-5. PubMed ID: 2894938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. N-Acetylation phenotyping with sulfamethazine--problems of sampling.
    Siegmund W; Franke G; Kibittel F; Krüger R
    Pharmazie; 1989 Oct; 44(10):729-30. PubMed ID: 2616620
    [No Abstract]   [Full Text] [Related]  

  • 45. [Occurrence of the fast acetylation phenotype in persons with the radicular syndrome. Preliminary report].
    Milejski P; Orzechowska-Juzwenko K; Tota B; Krzysztoń Z
    Neurol Neurochir Pol; 1987; 21(6):511-5. PubMed ID: 3449771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acetylation phenotype and skin complexion.
    Rampen FH; van der Meeren HL; Stolk LM
    Acta Derm Venereol; 1986; 66(4):334-6. PubMed ID: 2430405
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of acetylating capacity with complete Freund's adjuvant and hydrocortisone in the rabbit.
    du Souich P; Courteau H
    Drug Metab Dispos; 1981; 9(3):279-83. PubMed ID: 6113941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ecogenetic studies of drug acetylation in man and rats.
    Dubbels R; Khoory R; Schloot W
    Acta Anthropogenet; 1981; 5(2):111-8. PubMed ID: 7271997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-acetylation phenotyping with sulphadimidine in a Turkish population.
    Bozkurt A; Basci NE; Kalan S; Tuncer M; Kayaalp SO
    Eur J Clin Pharmacol; 1990; 38(1):53-6. PubMed ID: 2328748
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sulfadimidine and isoniazid loading in man and laboratory rats. Pharmacokinetic and pharmacogenetic results on drug acetylation.
    Dubbels R; Kattner E; Sell-Maurer D; Schloot W
    Arzneimittelforschung; 1980; 30(9):1574-9. PubMed ID: 7193028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
    Ylitalo P; Auterinen L; Marttinen A; Koivula T
    Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and pathological analyses of patients with a family history of colorectal cancer. Registry Committee, Japanese Research Society for Cancer of the Colon and Rectum.
    Jpn J Clin Oncol; 1993 Dec; 23(6):342-9. PubMed ID: 8283787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The relationship between the metabolism of procainamide and sulfamethazine.
    Giardina E-GV ; Stein RM; Bigger JT
    Circulation; 1977 Feb; 55(2):388-94. PubMed ID: 832354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bioavailability factors of isoniazid in fast and slow acetylators, healthy volunteers.
    Augustynowicz-Kopeć E; Zwolska Z
    Acta Pol Pharm; 2002; 59(6):452-7. PubMed ID: 12669770
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
    Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Acetylation phenotype in glomerulonephritis and its clinical significance].
    Milejski P; Orzechowska-Juzwenko K; Strychowski J; Szewczyk Z; Klinger M
    Pol Tyg Lek; 1987 May; 42(18):537-40. PubMed ID: 3628088
    [No Abstract]   [Full Text] [Related]  

  • 57. Dipyrone metabolism in liver disease.
    Zylber-Katz E; Caraco Y; Granit L; Levy M
    Clin Pharmacol Ther; 1995 Aug; 58(2):198-209. PubMed ID: 7648770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of phenazone oxidation and sulfadimidine acetylation in patients with hematologic neoplasms].
    Wiela-Hojeńska A; Milejski P; Orzechowska-Juzwenko K; Usnarska-Zubkiewicz L; Urbaniak-Kujda D; Kotlarek-Haus S
    Przegl Lek; 1997; 54(3):163-6. PubMed ID: 9297191
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alteration of hepatic acetylation in uraemia.
    Fine A; Sumner D
    Proc Eur Dial Transplant Assoc; 1975; 11():433-40. PubMed ID: 1197268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Features of the metabolic activity of the mononuclear phagocytic system in multiple sclerosis patients].
    Kovalev IE; Kovalev EN; Seleznev NG; Kuvshinova RL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):198-201. PubMed ID: 6711206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.